Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to 0.3%.

  • Arcturus Therapeutics Holdings' Return on Capital Employed fell 400.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.3% for FY2024, which is 800.0% down from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Return on Capital Employed of 0.3% as of Q3 2025, which was down 400.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed registered a high of 0.21% during Q1 2023, and its lowest value of 0.75% during Q1 2022.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed had a median value of 0.29% in 2024 and averaged 0.3%.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed surged by 9600bps in 2023 and then tumbled by -6100bps in 2024.
  • Arcturus Therapeutics Holdings' Return on Capital Employed (Quarter) stood at 0.65% in 2021, then skyrocketed by 108bps to 0.05% in 2022, then crashed by -535bps to 0.22% in 2023, then plummeted by -52bps to 0.33% in 2024, then rose by 9bps to 0.3% in 2025.
  • Its Return on Capital Employed was 0.3% in Q3 2025, compared to 0.26% in Q2 2025 and 0.28% in Q1 2025.